登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 3893 条符合本次的查询结果， 用时 2.7721366 秒

3541. Combined modality treatment of small cell lung cancer.

作者: O M Salazar.
来源: Chest. 1989年96卷1 Suppl期74S-78S页

3542. High-LET radiation therapy of non-small cell lung cancer.

作者: M Austin-Seymour.;T Griffin.;G Laramore.;M Maor.;R Parker.
来源: Chest. 1989年96卷1 Suppl期72S-73S页

3543. Hyperthermia in the management of lung cancer. The current situation.

作者: N M Bleehen.
来源: Chest. 1989年96卷1 Suppl期69S-71S页

3544. Altered fractionation for non-small cell carcinoma of the lung. Rationale for the prospective trials of the Radiation Therapy Oncology Group.

作者: J D Cox.;N Azarnia.;R W Byhardt.;C A Perez.;K Fu.;J J Spunberg.;W T Sause.
来源: Chest. 1989年96卷1 Suppl期68S-69S页

3545. High-dose chemotherapy in lung cancer.

作者: R L Souhami.
来源: Chest. 1989年96卷1 Suppl期66S-68S页

3546. Should we intensify the treatment of small cell lung cancer?

作者: J Aisner.
来源: Chest. 1989年96卷1 Suppl期64S-66S页

3547. Optimum duration of treatment with combination chemotherapy for small cell lung cancer.

作者: M H Cullen.
来源: Chest. 1989年96卷1 Suppl期62S-64S页

3548. Chemotherapy of small cell lung cancer.

作者: J F Smyth.
来源: Chest. 1989年96卷1 Suppl期61S-62S页
Selection of appropriate treatment is now possible on the basis of prognostic indices. For patients with a "poor" prognosis, therapy should be minimally toxic, for palliative purposes only. For patients with a "good" prognosis, intensive treatment is recommended with combinations comprised from C, A, V, VP-16, and CP. For patients obtaining a remission, consolidation is recommended with radiation treatment if this has not been part of the initial induction program with or without chemotherapy. Consolidation may be intensified by using high-dose chemotherapy in association with autologous bone marrow transplantation or possibly the use of hematopoietic growth factors. The major problem limiting further improvements in survival in this disease remains the emergence of drug resistance, which is now the subject of intensive investigations both in the laboratory and in the clinic.

3549. New treatments for small cell lung cancer. When to test.

作者: I E Smith.
来源: Chest. 1989年96卷1 Suppl期59S-61S页

3550. Innovative chemotherapy. Xenografts and in vitro drug sensitivity testing.

作者: A F Gazdar.
来源: Chest. 1989年96卷1 Suppl期56S-59S页

3551. Limited resection in the treatment of stage I non-small cell lung cancer; an overview.

作者: R J Ginsberg.
来源: Chest. 1989年96卷1 Suppl期50S-51S页

3552. Radiologic staging of lung cancer using CT and MRI.

作者: G M Glazer.
来源: Chest. 1989年96卷1 Suppl期44S-47S页

3553. Advances in the biology of lung cancer. Clinical significance of neuroendocrine differentiation.

作者: A F Gazdar.
来源: Chest. 1989年96卷1 Suppl期39S-41S页

3554. The clinical relevance of recent developments in pathology and biology of small cell lung cancer.

作者: F R Hirsch.;H H Hansen.
来源: Chest. 1989年96卷1 Suppl期34S-37S页

3555. Lung cancer and autocrine growth factors.

作者: K Yamaguchi.;K Imanishi.;K Maruno.;Y Miyake.;Y Shimosato.;K Abe.
来源: Chest. 1989年96卷1 Suppl期29S-31S页

3556. Monoclonal antibodies in lung cancer.

作者: R A Stahel.
来源: Chest. 1989年96卷1 Suppl期27S-29S页

3557. Oncogenes and genetic abnormalities in lung cancer.

作者: D N Carney.
来源: Chest. 1989年96卷1 Suppl期25S-27S页

3558. Quality of life assessment in patients with carcinoma of the lung.

作者: R Feld.
来源: Chest. 1989年96卷1 Suppl期105S-107S页

3559. Short- and long-term complications of coronary angioplasty.

作者: R A Lange.;L D Hillis.
来源: Chest. 1989年96卷1期151-7页

3560. Consensus conference on artificial airways in patients receiving mechanical ventilation.

作者: A L Plummer.;D R Gracey.
来源: Chest. 1989年96卷1期178-80页
共有 3893 条符合本次的查询结果， 用时 2.7721366 秒